Company intelligence / Profile preview

Egoo Health

Gothenburg, Sweden

Ownership: Private
Development stage: Other

Overview

Egoo Health's platform is CE-IVD marked and commercially available in Europe, providing point-of-care and at-home biomarker testing (including COVID-19 and hormone panels) with professional-grade accuracy, and ongoing expansion of assay menu to chronic disease and multiplexed viral testing[1][3][5].

Therapeutic areas: Infectious DiseasesEndocrinologyWomen's HealthMetabolic Disorders
Modalities: Device
Industry: Protein Biomarker Diagnostics

Partnerships

Hipro Biotechnology

Beyond the preview

Go deeper on Egoo Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Egoo Health.

Explore the full profile